Related Experiment Video
Updated: Jul 31, 2025

Induction of Atherosclerotic Plaques Through Activation of Mineralocorticoid Receptors in Apolipoprotein E-deficient Mice
Published on: September 26, 2018
(+)-Catechin Attenuates Multiple Atherosclerosis-Associated Processes In Vitro, Modulates Disease-Associated Risk
Yee-Hung Chan1, Joe W E Moss1, Jessica O Williams1
1Cardiff School of Biosciences, Cardiff University, Sir Martin Evans Building, Museum Avenue, Cardiff, CF10 3AX, UK.
Insights
(+)-Catechin, a compound found in green tea, shows promise in preventing heart disease. This study reveals its protective effects against atherosclerosis by reducing inflammation and improving key cardiovascular risk factors.
Area of Science:
- Cardiovascular Science
- Nutritional Biochemistry
- Molecular Biology
Background:
- Coronary heart disease (CHD) remains a leading cause of mortality worldwide.
- (+)-Catechin intake is inversely associated with CHD risk in large human studies.
- The precise mechanisms by which (+)-catechin exerts its cardioprotective effects are not fully understood.
Purpose of the Study:
- To investigate the molecular mechanisms underlying the cardioprotective effects of (+)-catechin.
- To evaluate the impact of (+)-catechin on atherosclerosis and related risk factors in cellular and animal models.
Main Methods:
- In vitro studies using human macrophages, endothelial cells, and vascular smooth muscle cells.
- In vivo studies using C57BL/6J mice and LDL receptor-deficient mice fed a high-fat diet.
- Analysis of gene expression, cellular proliferation, migration, and inflammatory markers.
Main Results:
- (+)-Catechin attenuated reactive oxygen species production, monocytic migration, and pro-atherogenic gene expression in human cells.
- In mice, (+)-catechin reduced plasma triacylglycerol, inflammatory cytokines (IL-1β, IL-2), and altered bone marrow cell populations.
- In LDL receptor-deficient mice, (+)-catechin significantly reduced atherosclerotic plaque burden, inflammation, and enhanced plaque stability.
Conclusions:
- (+)-Catechin demonstrates significant cardio-protective actions through multiple molecular pathways.
- The findings provide detailed insights into the anti-atherogenic properties of (+)-catechin.
- This study supports further clinical investigation of (+)-catechin for cardiovascular disease prevention.
Scope:
A prospective study of 34492 participants shows an inverse association between (+)-catechin intake and coronary heart disease. The effects of (+)-catechin on atherosclerosis and associated risk factors are poorly understood and are investigated.
Methods And Results:
(+)-Catechin attenuates reactive oxygen species production in human macrophages, endothelial cells and vascular smooth muscle cells, chemokine-driven monocytic migration, and proliferation of human macrophages and their expression of several pro-atherogenic genes. (+)-Catechin also improves oxidized LDL-mediated mitochondrial membrane depolarization in endothelial cells and attenuates growth factor-induced smooth muscle cell migration. In C57BL/6J mice fed high fat diet (HFD) for 3 weeks, (+)-catechin attenuates plasma levels of triacylglycerol and interleukin (IL)-1β and IL-2, produces anti-atherogenic changes in liver gene expression, and reduces levels of white blood cells, myeloid-derived suppressor cells, Lin- Sca+ c-Kit+ cells, and common lymphoid progenitor cells within the bone marrow. In LDL receptor deficient mice fed HFD for 12 weeks, (+)-catechin attenuates atherosclerotic plaque burden and inflammation with reduced macrophage content and increased markers of plaque stability; smooth muscle cell and collagen content.
Conclusion:
This study provides novel, detailed insights into the cardio-protective actions of (+)-catechin together with underlying molecular mechanisms and supports further assessments of its beneficial effects in human trials.
Related Concept Videos
Atherosclerosis I: Introduction
Atherosclerosis III: Management
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease IV: Preventive Measures
Inflammation

